Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00096772
Other study ID # CPCRA 066
Secondary ID 10052
Status Completed
Phase N/A
First received November 15, 2004
Last updated May 16, 2014
Start date January 2005
Est. completion date September 2007

Study information

Verified date May 2014
Source National Institute of Allergy and Infectious Diseases (NIAID)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

The purpose of this study is to collect blood samples from HIV infected individuals for use in future genetic studies.


Description:

Genetic differences among people with HIV may account for differences in disease progression and response to antiretroviral therapy. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) was created to conduct studies in HIV infected communities and particularly in people of color, women, and injection drug users. This study will collect whole blood samples from HIV infected individuals. The samples will be used in future CPCRA studies comparing human genetic factors with clinical data from other CPCRA studies.


Recruitment information / eligibility

Status Completed
Enrollment 2502
Est. completion date September 2007
Est. primary completion date September 2007
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Presently participating, previously participated in, or has given informed consent for participation in a qualifying CPCRA clinical trial

- Signed informed consent

Study Design

N/A


Related Conditions & MeSH terms


Locations

Country Name City State
United States Earl K. Long Med. Ctr., LSU - Mid City EIC Clinic CRS Baton Rouge Louisiana
United States James Osterberger, MD (Private Med. Practice) CRS Baton Rouge Louisiana
United States CRI-Boston CRS Boston Massachusetts
United States Beacon Clinic at Boulder CRS Boulder Colorado
United States Bronx- Lebanon Hospital Center Clinical Research Site (BLHC CRS) Bronx New York
United States Bronx-Lebanon Hosp. Ctr. CRS Bronx New York
United States Montefiore Med. Ctr., AIDS Ctr. CRS Bronx New York
United States Cooper Hospital/Univ. Med. Ctr., The Cooper Early Intervention Program (EIP) CRS Camden New Jersey
United States Cooper Univ. Hosp. CRS Camden New Jersey
United States Klein & Slotten Medical Associates CRS Chicago Illinois
United States Lakeshore Infectious Disease Associates CRS Chicago Illinois
United States North Side Family Medicine CRS Chicago Illinois
United States Univ. of Illinois Family Ctr. for Infectious Disease CRS Chicago Illinois
United States APEX Family Medicine CRS Denver Colorado
United States Denver Infectious Diseases Consultants CRS Denver Colorado
United States Denver Public Health CRS Denver Colorado
United States Denver Public Health CRS - INSIGHT Denver Colorado
United States Eastside Family Health Ctr. CRS Denver Colorado
United States Kaiser Permanente of Denver CRS Denver Colorado
United States South Denver Infectious Diseases Specialists, Accord Med. Ctr. CRS Denver Colorado
United States Univ. of Colorado Health Science Ctr. CRS Denver Colorado
United States Detroit Community Health Connection, Inc. CRS Detroit Michigan
United States Harper Hosp., Detroit CRS Detroit Michigan
United States Henry Ford Hosp. CRS Detroit Michigan
United States Henry Ford Hosp., Div. of Infectious Disease INSIGHT CRS Detroit Michigan
United States Wayne State Univ. CRS Detroit Michigan
United States Wayne State Univ. INSIGHT CRS Detroit Michigan
United States MediCorp, Infectious Disease Associates CRS Fredericksburg Virginia
United States Georgetown Wellness Clinic Georgetown Delaware
United States ID Care Inc. - Hillsborough CRS Hillsborough New Jersey
United States Baylor College of Medicine, Thomas St. Clinic CRS Houston Texas
United States Houston AIDS Research Team CRS Houston Texas
United States Michael E. DeBakey VAMC CRS Houston Texas
United States Thomas Street Clinic CRS Houston Texas
United States Univ. of Mississippi Med. Ctr., Div. of Infectious Diseases CRS Jackson Michigan
United States Michigan State Univ., Infectious Disease Clinic CRS Lansing Michigan
United States Dr. M. Estes Med. Practice CRS Mill Valley California
United States Jersey Shore Univ. Med. Ctr. CRS Neptune New Jersey
United States Yale Univ. School of Medicine, NE ProACT - New Haven CRS New Haven Connecticut
United States Med. Ctr. of Louisiana at New Orleans, HIV Outpatient Clinics CRS New Orleans Louisiana
United States New Orleans VAMC CRS New Orleans Louisiana
United States Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS New Orleans Louisiana
United States Harlem Hosp. Ctr., Outpatient Clinics (New York) CRS New York New York
United States Harlem Hospital Ctr./Columbia University CRS (Gordin CTU) New York New York
United States St. Vincent Hosp. & Med. Ctr. CRS New York New York
United States Cathedral Healthcare System, St. Michael's Med. Ctr. CRS Newark New Jersey
United States New Jersey Community Research Initiative, Jeffrey Bomser Clinic CRS Newark New Jersey
United States Dr. Robert Scott Med. Practice CRS Oakland California
United States East Bay AIDS Ctr. CRS Oakland California
United States St. Joseph's Hosp. & Med. Ctr. of New Jersey Paterson New Jersey
United States St. Joseph's Hosp. & Med. Ctr. of New Jersey CRS Paterson New Jersey
United States Raritan Bay Med. Ctr., Perth Amboy Division CRS Perth Amboy New Jersey
United States Petersburg Health Care Alliance CRS Petersburg Virginia
United States Temple Univ. School of Medicine CRS Philadelphia Pennsylvania
United States Kaiser Immune Deficiency Clinic of Portland CRS Portland Oregon
United States Legacy Clinic Emanuel CRS Portland Oregon
United States Legacy Clinic Good Samaritan CRS Portland Oregon
United States Legacy Clinic Northeast CRS Portland Oregon
United States Multnomah County Health Dept., HIV Health Services Ctr. CRS Portland Oregon
United States Oregon Health & Sciences Univ. Internal Medicine (L-475) CRS Portland Oregon
United States Providence Portland Med. Ctr., Ambulatory Care and Education Ctr. CRS Portland Oregon
United States The Research & Education Group-Portland CRS Portland Oregon
United States ID Care - Randolph CRS Randolph New Jersey
United States CrossOver Health Ctr. CRS Richmond Virginia
United States Hunter Holmes McGuire VAMC CRS Richmond Virginia
United States South Richmond Health Care Ctr. CRS Richmond Virginia
United States VCU Health Systems, Infectious Disease Clinic CRS Richmond Virginia
United States Vernon Harris East End Community Health Ctr. CRS Richmond Virginia
United States Virginia Commonwealth Univ. Medical Ctr. CRS Richmond Virginia
United States Castro-Mission Health Ctr. CRS San Francisco California
United States Dr. Shawn Hassler Med. Practice CRS San Francisco California
United States Dr. Virginia Cafaro Med. Practice CRS San Francisco California
United States Dr. William Owen Med. Practice CRS San Francisco California
United States Positive Health Program Clinic (San Francisco Gen. Hosp.) CRS San Francisco California
United States San Francisco VAMC, Infectious Diseases Clinic CRS San Francisco California
United States St. Mary's Med. Ctr. of San Francisco CRS San Francisco California
United States UCSF PHP, Gen. Internal Medicine Practice CRS San Francisco California
United States CRI-Springfield CRS Springfield Massachusetts
United States Infectious Disease Specialists of N.J., North Jersey Community Research Initiative CRS Union New Jersey
United States The Early Intervention Program at Kennedy Hosp. CRS Voorhees New Jersey
United States Washington DC VAMC, Washington Regional AIDS Program, Infectious Diseases CRS Washington District of Columbia
United States Western Infectious Disease Consultants CRS Wheat Ridge Colorado
United States Christiana Care Health Services HIV Program CRS Wilmington Delaware

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Allergy and Infectious Diseases (NIAID)

Country where clinical trial is conducted

United States, 

References & Publications (3)

Anastassopoulou CG, Kostrikis LG. The impact of human allelic variation on HIV-1 disease. Curr HIV Res. 2003 Apr;1(2):185-203. Review. — View Citation

O'Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet. 2004 Jun;36(6):565-74. Review. — View Citation

Telenti A. The genetic cohorts: facing the new challenges in infectious diseases. The HIV model. Enferm Infecc Microbiol Clin. 2004 Jun-Jul;22(6):337-41. Review. — View Citation

See also
  Status Clinical Trial Phase
Completed NCT05454514 - Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS N/A
Completed NCT03760458 - The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age Phase 1/Phase 2
Completed NCT03141918 - Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS N/A
Completed NCT03067285 - A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study Phase 4
Recruiting NCT04579146 - Coronary Artery Disease (CAD) in Patients HIV-infected
Completed NCT06212531 - Papuan Indigenous Model of Male Circumcision N/A
Active, not recruiting NCT03256422 - Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients Phase 3
Completed NCT03256435 - Retention in PrEP Care for African American MSM in Mississippi N/A
Completed NCT00517803 - Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies N/A
Active, not recruiting NCT03572335 - Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
Completed NCT04165200 - Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV N/A
Recruiting NCT03854630 - Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection Phase 4
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT02234882 - Study on Pharmacokinetics Phase 1
Completed NCT01618305 - Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission Phase 4
Recruiting NCT05043129 - Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
Not yet recruiting NCT05536466 - The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine N/A
Recruiting NCT04985760 - Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy Phase 1
Completed NCT05916989 - Stimulant Use and Methylation in HIV
Terminated NCT02116660 - Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284) Phase 2